Wolverine Trading, LLC Celldex Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $45,220 - $81,300	2,000 Added 16.13%	14,400 $571,000
Q3 2023 Nov 15, 2023	SELL	$25.45 - $37.46 $45,810 - $67,428	-1,800 Reduced 12.68%	12,400 $341,000
Q2 2023 Aug 23, 2023	BUY	$30.29 - $38.28 $430,118 - $543,576	14,200 New	14,200 $481,000
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $147,234 - $240,514	5,300 New	5,300 $236,000
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $129,150 - $235,179	6,300 Added 59.43%	16,900 $470,000
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $44,224 - $62,912	-1,600 Reduced 13.11%	10,600 $367,000
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $192,672 - $303,858	5,400 Added 79.41%	12,200 $475,000
Q3 2021 Nov 12, 2021	SELL	$28.95 - $55.99 $121,590 - $235,158	-4,200 Reduced 38.18%	6,800 $353,000
Q2 2020 Aug 13, 2020	BUY	$1.61 - $13.41 $483 - $4,023	300 Added 2.8%	11,000 $137,000
Q2 2019 Aug 20, 2019	BUY	$2.43 - $5.09 $26,001 - $54,463	10,700 New	10,700 $29,000

206

70.2M

1.46M

868K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.06B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.